Welcome to our searchable resource and literature collection on safer supply and related topics.
Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.
Resources
Commentary | 2019
Policy/Regulatory, About prescribers, Chronic pain
During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals. The impact of COVID-19 on the supply of MOUD in U.S.
Original research | 2022
Policy/Regulatory, Legal system/law enforcement, Substitution/OAT
Aims: To determine 1. The characteristics of all recorded cases of fatal drug poisoning involving novel synthetic opioids (NSOs) in Australia; 2. The toxicology of cases; and 3.
Original research | 2022
Overdose, Mortality, About PWUD, Outcomes, Illegal drugs, Drug checking
Heroin-assisted treatment (HAT) can improve the condition of heroin addicts still using street heroin after a methadone treatment.
Original research | 2015
Evidence base, Safer supply, About PWUD, Outcomes, Crime, Illegal drugs, Substitution/OAT
The Ontario COVID-19 OAT Treatment Guidance document was developed to facilitate access to OAT and continuity of care during the pandemic, while supporting physical distancing measures.
Original research | 2021
Evidence base, Policy/Regulatory, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, About PWUD, Substitution/OAT
Commentary | 2021
Policy/Regulatory, Illegal drugs
Report | 2021
Harm reduction, Safer supply, About prescribers
If a client becomes aggressive, threatening or potentially violent, it is important for service providers to respond in accordance with the policies and procedures specific to their service.
Webpage | 2016
Harm reduction, About pharmacists, About prescribers, About PWUD, Social services, Illegal drugs, Workplace, SCS/OPS
Commentary | 2017
Policy/Regulatory, Wrap-around services, Equity, Advocacy, About prescribers, Illegal drugs, Substitution/OAT
Patients with medically-treated opioid overdose are at high risk for subsequent adverse outcomes, including repeat overdose.
Original research | 2022
Overdose, Harm reduction, About PWUD, Outcomes, Illegal drugs, Substitution/OAT
The aim of the study is to present autopsy-based findings of the most prevalent opioids in overdose deaths in Norway from 2000 to 2019
Original research | 2022
Overdose, Mortality, Safer supply, About PWUD, Outcomes, Illegal drugs
This study deploys the Theory of Planned Behavior (TPB) to understand what influences police intentions to make discretionary referrals to treatment and harm reduction resources rather than arrest on
Original research | 2021
Social services, Legal system/law enforcement, Illegal drugs, Transitions in care/treatment, Stigma
Examine during- and post-prison outcomes among people prescribed OAT
Commentary | 2022
Harm reduction, Wrap-around services, About PWUD, Social services, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT
Our objective was to assess prescription history in the context of postmortem toxicology among people who had a fatal illicit drug overdose in BC.
Original research | 2020
Overdose, Mortality, Evidence base, Safer supply, Outcomes, Illegal drugs, Stimulants
This study assessed the safety of subcutaneous slow-release depot buprenorphine in custody.
Original research | 2022
Outcomes, Legal system/law enforcement, Substitution/OAT, Diversion
The aim of this work was to understand (1) the perspectives of family physicians (FPs) as it relates to opioid prescribing, and (2) the perceived barriers and enablers to guideline-adherent opioid pre
Original research | 2019
Clinical guidance, Policy/Regulatory, Hesitancy of prescribers , Safer supply, About prescribers, Barriers and enablers, Chronic pain
We report evidence that study subjects probably medicated their ADHD symptoms with cocaine and describe a 1‐year treatment algorithm featuring long‐acting stimulants that was effective in the manageme
Original research | 1999
About prescribers, Outcomes, Illegal drugs, Stimulants
Cannabis legalization in many jurisdictions worldwide has raised concerns that such legislation might increase the burden of transient and persistent psychotic illnesses in society.
Original research | 2022
Policy/Regulatory, Mental health
The people who frequent the Integrated Care Hub (ICH) – its stakeholders – know best what they are experiencing and what they need.
Report | 2021
Overdose, Evidence base, Harm reduction, Policy/Regulatory, Wrap-around services, Safer supply, Decriminalization/legalization, Equity, About PWUD, Social services, Barriers and enablers, Poverty, Housing, Crime, Legal system/law enforcement, Illegal drugs, Chronic pain, Indigenous, Small/medium cities, Stimulants, Sex/Gender , Stigma, Mental health
Examined racial/ethnic differences in US drug overdose mortality among US-born and foreign-born men and women.
Original research | 2022
Overdose, Mortality, Equity, Illegal drugs
